APC germline pathogenic variants and epithelial ovarian cancer: causal or coincidental findings?

被引:1
作者
Vibert, Roseline [1 ,2 ]
Le Gall, Jessica [1 ,3 ]
Buecher, Bruno [1 ,2 ]
Mouret-Fourme, Emmanuelle [1 ,2 ]
Bataillon, Guillaume [2 ,4 ]
Becette, Veronique [2 ,4 ]
Trabelsi-Grati, Olfa [1 ,2 ]
Moncoutier, Virginie [1 ,2 ]
Dehainault, Catherine [1 ,2 ]
Carriere, Jennifer [1 ,2 ]
Schwartz, Mathias [1 ,2 ]
Suybeng, Voreak [1 ,2 ]
Bieche, Ivan [1 ,3 ]
Colas, Chrystelle [1 ,2 ]
Vincent-Salomon, Anne [2 ,4 ]
Stoppa-Lyonnet, Dominique [1 ,3 ,5 ]
Golmard, Lisa [1 ,2 ]
机构
[1] Inst Curie, Dept Genet, Paris, France
[2] PSL Res Univ, Paris, France
[3] Univ Paris, Paris, Ile De France, France
[4] Inst Curie, Dept Pathol, Paris, France
[5] Inst Curie, INSERM, U830, Paris, France
关键词
Genetics; MICROCYSTIC STROMAL TUMOR; ADENOMATOUS POLYPOSIS; HAPLOINSUFFICIENCY; MANIFESTATION; CATENIN; MODEL;
D O I
10.1136/jmg-2022-108467
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
APC germline pathogenic variants result in predisposition to familial adenomatous polyposis and extraintestinal tumours such as desmoid fibromatosis, medulloblastomas and thyroid cancers. They have also been recently involved in ovarian microcystic stromal tumours. APC inactivation has been described at the tumour level in epithelial ovarian cancers (EOCs). Here, we report the identification of APC germline pathogenic variants in two patients diagnosed with premenopausal EOC in early 30s, with no other pathogenic variant detected in the known ovarian cancer predisposing genes. Subsequent tumour analysis showed neither a second hit of APC inactivation nor beta-catenin activation. Both tumours did not have a homologous recombination (HR) deficiency, pointing towards the implication of other genes than those involved in HR. APC may contribute to the carcinogenesis of EOC in a multifactorial context. Further studies are required to clarify the role of APC in predisposition to EOC.
引用
收藏
页码:460 / 463
页数:4
相关论文
共 22 条
  • [1] Monoallelic silencing and haploinsufficiency in early murine intestinal neoplasms
    Amos-Landgraf, James M.
    Irving, Amy A.
    Hartman, Cory
    Hunter, Anthony
    Laube, Brianna
    Chen, Xiaodi
    Clipson, Linda
    Newton, Michael A.
    Dove, William F.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (06) : 2060 - 2065
  • [2] Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
    Angeli, Davide
    Salvi, Samanta
    Tedaldi, Gianluca
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [3] Integrated genomic analyses of ovarian carcinoma
    Bell, D.
    Berchuck, A.
    Birrer, M.
    Chien, J.
    Cramer, D. W.
    Dao, F.
    Dhir, R.
    DiSaia, P.
    Gabra, H.
    Glenn, P.
    Godwin, A. K.
    Gross, J.
    Hartmann, L.
    Huang, M.
    Huntsman, D. G.
    Iacocca, M.
    Imielinski, M.
    Kalloger, S.
    Karlan, B. Y.
    Levine, D. A.
    Mills, G. B.
    Morrison, C.
    Mutch, D.
    Olvera, N.
    Orsulic, S.
    Park, K.
    Petrelli, N.
    Rabeno, B.
    Rader, J. S.
    Sikic, B. I.
    Smith-McCune, K.
    Sood, A. K.
    Bowtell, D.
    Penny, R.
    Testa, J. R.
    Chang, K.
    Dinh, H. H.
    Drummond, J. A.
    Fowler, G.
    Gunaratne, P.
    Hawes, A. C.
    Kovar, C. L.
    Lewis, L. R.
    Morgan, M. B.
    Newsham, I. F.
    Santibanez, J.
    Reid, J. G.
    Trevino, L. R.
    Wu, Y. -Q.
    Wang, M.
    [J]. NATURE, 2011, 474 (7353) : 609 - 615
  • [4] A continuum model for tumour suppression
    Berger, Alice H.
    Knudson, Alfred G.
    Pandolfi, Pier Paolo
    [J]. NATURE, 2011, 476 (7359) : 163 - 169
  • [5] Germline pathogenic variants identified in women with ovarian tumors
    Carter, Natalie J.
    Marshall, Megan L.
    Susswein, Lisa R.
    Zorn, Kristin K.
    Hiraki, Susan
    Arvai, Kevin J.
    Torene, Rebecca I.
    McGill, Anna K.
    Yackowski, Lauren
    Murphy, Patricia D.
    Xu, Zhixiong
    Solomon, Benjamin D.
    Klein, Rachel T.
    Hruska, Kathleen S.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 151 (03) : 481 - 488
  • [6] Target-Enriched Next-Generation Sequencing Reveals Differences between Primary and Secondary Ovarian Tumors in Formalin-Fixed, Paraffin-Embedded Tissue
    Crobach, Stijn
    Ruano, Dina
    van Eijk, Ronald
    Fleuren, Gert Jan
    Minderhout, Ivonne
    Snowdowne, Robelle
    Tops, Carli
    van Wezel, Tom
    Morreau, Hans
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (02) : 193 - 200
  • [7] Bonadio RRDC, 2018, CLINICS, V73
  • [8] Familial Adenomatous Polyposis Syndrome An Update and Review of Extraintestinal Manifestations
    Dinarvand, Peyman
    Davaro, Elizabeth P.
    Doan, James, V
    Ising, Mary E.
    Evans, Neil R.
    Phillips, Nancy J.
    Lai, Jinping
    Guzman, Miguel A.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (11) : 1382 - 1398
  • [9] ShallowHRD: detection of homologous recombination deficiency from shallow whole genome sequencing
    Eeckhoutte, Alexandre
    Houy, Alexandre
    Manie, Elodie
    Reverdy, Manon
    Bieche, Ivan
    Marangoni, Elisabetta
    Goundiam, Oumou
    Vincent-Salomon, Anne
    Stoppa-Lyonnet, Dominique
    Bidard, Francois-Clement
    Stern, Marc-Henri
    Popova, Tatiana
    [J]. BIOINFORMATICS, 2020, 36 (12) : 3888 - 3889
  • [10] Extra-intestinal manifestations of familial adenomatous polyposis
    Groen, Emma J.
    Roos, Annemieke
    Muntinghe, Friso L.
    Enting, Roelien H.
    de Vries, Jakob
    Kleibeuker, Jan H.
    Witjes, Max J. H.
    Links, Thera P.
    van Beek, Andre P.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (09) : 2439 - 2450